BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CareMed Pharmaceutical Services Selected to Distribute Astellas Pharma US and Genentech (RHHBY)'s Oncology Drug Tarceva


7/30/2013 10:33:41 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAKE SUCCESS, NY (JULY 30, 2013) - CareMed Pharmaceutical Services has been selected to supply oncology drug Tarceva (Erlotinib). Genentech and Astellas Pharma US, the manufacturer of Tarceva, stopped distributing the medication through retail pharmacies on July 1. CareMed joins an elite network of specialty pharmacies authorized to dispense the limited distribution oncology medication.

Tarceva is a once daily oral non-chemotherapy cancer treatment. Tarceva is a targeted cancer treatment approved by the Food and Drug Administration (FDA) for maintenance therapy and second- or third-line therapy for advanced non-small cell lung cancer (NSCLC). Tarceva is prescribed for patients with advanced-stage, non-small cell lung cancer (NSCLC) whose cancer has not spread or grown after initial treatment with certain types of chemotherapy. Tarceva is prescribed for patients with advanced-stage NSCLC whose cancer has spread or grown after receiving at least one chemotherapy regimen. Tarceva is not meant to be used at the same time as certain types of chemotherapy for advanced NSCLC. Tarceva gained FDA approval in May 2013 as a first-line treatment of NSCLC.

“CareMed is honored to be able to continue supplying our patients with Tarceva,” said John Witkowski, Senior Vice President of Sales & Marketing for CareMed. “In 2013, The American Cancer Society estimates 228,000 Americans will be diagnosed with lung cancer, with NSCLC accounting for 85 percent of lung cancer cases. Of these, the majority of people diagnosed will already be in an advanced stage of the disease. ”

Tarceva is not a chemotherapy drug. Tarceva is a targeted cancer treatment which is a kind of therapy that affects certain signals needed for cancer cells to grow. It may also impact healthy cells. Tarceva may slow or block the activity of a specific protein called epidermal growth factor receptor 1 (HER1/EGFR). Cancer cells need this protein to grow and divide.

“CareMed is proud to continue to have access to Tarceva and to be one of a highly elite network of suppliers capable of supplying this oral oncology treatment to our patients,” Witkowski reports. “At CareMed, we work tirelessly to meet the needs 24/7 of the physicians and patients that count on us as their specialty pharmacy of choice and we do not take that responsibility lightly.”

About CareMed Pharmaceutical Services

CareMed Pharmaceutical Services is a National Accredited Specialty Pharmacy, providing superior, individualized and reliable pharmaceutical care to its clients. For more than 40 years, CareMed’s mission has been to fulfill the needs of patients, physicians, and hospitals with a seamless, integrated delivery system of oral and injectable medications necessary in today's health care and home care environments. CareMed's highly skilled staff of professionals all work toward this goal by providing high-quality, efficient, and cost-effective service on a daily basis. The specialty pharmacy provides comprehensive disease-specific care management programs, utilization reviews, quality control audits, clinical consultations, medication compliance monitoring, and timely worry-free refill services all in adherence with USP 797.

CareMed Pharmaceutical Services provides: Prescription service 24/7/365; Time sensitive, accurate deliveries nationally; Toll-free telephone and fax lines to reach our pharmacists; Pharmacist consultants and nurse consultants to provide the best possible care; Patient, provider, and payer education and consulting; Preceptor-ship programs and clinical workshops; Regulation compliance assistance; Custom reporting for patient and financial management; Drug trend analysis; Customized medication packaging systems; Disease Specific Care Management; A full line of products, including IV medications, enteral nutrition and medical supplies; Reimbursement insurance assistance; Patient Assistance Programs, when applicable; Multilingual customer service representatives. CareMed strives to do whatever it takes to get medications approved by insurance companies so that patients can focus on recovery. When there are high copays, the specialty pharmacy can reach out to copay assistance providers that enroll patients for financial aid.

For more information, call (877) 227-3405 or visit CareMed online at www.caremedps.com.

For more information about Tarceva, visit http://www.tarceva.com/patient/considering.

MEDIA CONTACT:

Marie Alonso

Public & Media Relations

malonso@milestechnologies.com

800-496-8001

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES